CHIMIA

Login SCG Membership

CHIMIA, Vol. 58, Issue 09/2004

Molecular Informatics as an Enabling in silico Technology Platform for Drug Discovery

SpeedScreen, a Label-Free, Affinity-Based High-Throughput Screening Technology for the Discovery of Orphan Protein Ligands

Lead Generation: Sowing the Seeds for Future Success

Small Molecule Drug Discovery in the Fast-Changing World of Biotechnology

Drug Discovery in Oncology

5-HT2C Receptor Agonists for the Treatment of Obesity. Biological and Chemical Adventures

The Synthetic Development of the Anti-Influenza Neuraminidase Inhibitor Oseltamivir Phosphate (Tamiflu®): A Challenge for Synthesis & Process Research

2-Styryl-pyridines and 2-(3,4-Dihydro-naphthalen-2-yl)-pyridines as Potent NR1/2B Subtype Selective NMDA Receptor Antagonists

Inhibitors of Plasmepsin II – Potential Antimalarial Agents

Broad Spectrum Chemistry as Practised by Novartis Process Research

Increased Productivity through Dynamic Process Optimization in Sterile Facility 303 at Novartis

Abschied von der Abteilung Chemie in Burgdorf: Offener Brief an alle Burgdorfer Chemikerinnen und Chemiker

Lectures, Congresses – Conferences – Workshops

Preisausschreibung - Mise au concours

CHIMIA-Report, 2004/09

Var. Informations

Contents - Inhalt - Sommaire